These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36925697)

  • 41. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.
    Chassaing B; Koren O; Goodrich JK; Poole AC; Srinivasan S; Ley RE; Gewirtz AT
    Nature; 2015 Mar; 519(7541):92-6. PubMed ID: 25731162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease.
    Augustyn M; Grys I; Kukla M
    Clin Exp Hepatol; 2019 Mar; 5(1):1-10. PubMed ID: 30915401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial proteins in intestine and inflammatory bowel diseases.
    Kim JM
    Intest Res; 2014 Jan; 12(1):20-33. PubMed ID: 25349560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota.
    Wang P; Gao J; Ke W; Wang J; Li D; Liu R; Jia Y; Wang X; Chen X; Chen F; Hu X
    Free Radic Biol Med; 2020 Aug; 156():83-98. PubMed ID: 32305646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oenothein B ameliorates hepatic injury in alcoholic liver disease mice by improving oxidative stress and inflammation and modulating the gut microbiota.
    Xu L; Li W; Chen SY; Deng XW; Deng WF; Liu G; Chen YJ; Cao Y
    Front Nutr; 2022; 9():1053718. PubMed ID: 36579073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of the effects of different fucoidans on cefoperazone-induced gut microbiota disturbance and intestinal inflammation.
    Luo J; Wang Z; Fan B; Wang L; Liu M; An Z; Zhao X
    Food Funct; 2021 Oct; 12(19):9087-9097. PubMed ID: 34388231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal environmental disorders associate with the tissue damages induced by perfluorooctane sulfonate exposure.
    Wang G; Sun S; Wu X; Yang S; Wu Y; Zhao J; Zhang H; Chen W
    Ecotoxicol Environ Saf; 2020 Jul; 197():110590. PubMed ID: 32283409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats.
    Iacob S; Iacob DG; Luminos LM
    Front Microbiol; 2018; 9():3328. PubMed ID: 30761120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic administration of the recombinant antimicrobial peptide microcin J25 effectively enhances host defenses against gut inflammation and epithelial barrier injury induced by enterotoxigenic Escherichia coli infection.
    Yu H; Wang Y; Zeng X; Cai S; Wang G; Liu L; Huang S; Li N; Liu H; Ding X; Song Q; Qiao S
    FASEB J; 2020 Jan; 34(1):1018-1037. PubMed ID: 31914603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cationic, amphipathic small molecules based on a triazine-piperazine-triazine scaffold as a new class of antimicrobial agents.
    Dinesh Kumar S; Park JH; Kim HS; Seo CD; Ajish C; Kim EY; Lim HS; Shin SY
    Eur J Med Chem; 2022 Dec; 243():114747. PubMed ID: 36103802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baicalin Alleviates Short-Term Lincomycin-Induced Intestinal and Liver Injury and Inflammation in Infant Mice.
    Zhang S; Zhong R; Tang S; Han H; Chen L; Zhang H
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chlorogenic Acid Protects Against Indomethacin-Induced Inflammation and Mucosa Damage by Decreasing
    Yan Y; Zhou X; Guo K; Zhou F; Yang H
    Front Immunol; 2020; 11():1125. PubMed ID: 32582202
    [No Abstract]   [Full Text] [Related]  

  • 57. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy.
    Whitfield-Cargile CM; Cohen ND; Chapkin RS; Weeks BR; Davidson LA; Goldsby JS; Hunt CL; Steinmeyer SH; Menon R; Suchodolski JS; Jayaraman A; Alaniz RC
    Gut Microbes; 2016 May; 7(3):246-61. PubMed ID: 27007819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats.
    Ning Y; Gong Y; Zheng T; Xie Y; Yuan S; Ding W
    Diabetes Metab Syndr Obes; 2022; 15():2427-2442. PubMed ID: 35971521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lights and Shadows on the Therapeutic Use of Antimicrobial Peptides.
    Bellotti D; Remelli M
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice.
    Pötgens SA; Thibaut MM; Joudiou N; Sboarina M; Neyrinck AM; Cani PD; Claus SP; Delzenne NM; Bindels LB
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):456-475. PubMed ID: 33599103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.